本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pyxis Oncology, Inc.

1.02
+0.105011.48%
盘后1.020.00000.00%19:27 EDT
成交量:51.56万
成交额:51.14万
市值:6,282.22万
市盈率:-0.77
高:1.03
开:0.9055
低:0.9055
收:0.9150
数据加载中...
2024/04/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/02

SEC问询函

Form CORRESP - Correspondence
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/13

重要事件披露

Form 8-K - Current report
2024/03/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/27

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/28

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities